昂利康：创新药产品目前处于早期临床阶段

Core Viewpoint - The company announced that its innovative drug products are currently in the early clinical stages, with a focus on building clinical and medical teams [2] Group 1 - The company is prioritizing the establishment of clinical and medical teams at this stage [2] - Future commercialization plans for related products will depend on the progress of clinical research [2] - The company aims to leverage clinical research outcomes to plan and advance its product commercialization at the appropriate time [2]